Does TOFACITINIB Cause Infusion related reaction? 5,046 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5,046 reports of Infusion related reaction have been filed in association with TOFACITINIB (XELJANZ XR). This represents 3.2% of all adverse event reports for TOFACITINIB.
5,046
Reports of Infusion related reaction with TOFACITINIB
3.2%
of all TOFACITINIB reports
1,636
Deaths
2,115
Hospitalizations
How Dangerous Is Infusion related reaction From TOFACITINIB?
Of the 5,046 reports, 1,636 (32.4%) resulted in death, 2,115 (41.9%) required hospitalization, and 1,801 (35.7%) were considered life-threatening.
Is Infusion related reaction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 5,046 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Infusion related reaction?
INFLIXIMAB (12,946)
RITUXIMAB (11,871)
TOCILIZUMAB (8,340)
METHOTREXATE (7,225)
ADALIMUMAB (6,865)
ABATACEPT (6,759)
PREDNISONE (6,481)
LEFLUNOMIDE (6,205)
HYDROXYCHLOROQUINE (5,991)
ETANERCEPT (5,960)
Which TOFACITINIB Alternatives Have Lower Infusion related reaction Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN